CUSIP: 87583X109
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
135,353,744
-
Total 13F shares
-
172,390,695
-
Share change
-
+32,036,222
-
Total reported value
-
$1,527,338,103
-
Put/Call ratio
-
55%
-
Price per share
-
$8.86
-
Number of holders
-
169
-
Value change
-
+$294,868,789
-
Number of buys
-
124
-
Number of sells
-
48
Quarterly Holders Quick Answers
What is CUSIP 87583X109?
CUSIP 87583X109 identifies TNGX - Tango Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 87583X109:
Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q4 2025
As of 31 Dec 2025,
Tango Therapeutics, Inc. - Common Stock (TNGX) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
172,390,695 shares.
The largest 10 holders included
FARALLON CAPITAL MANAGEMENT LLC, TCG Crossover Management, LLC, Boxer Capital Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Woodline Partners LP, BlackRock, Inc., Siren, L.L.C., TRV GP IV, LLC, Nextech Invest, Ltd., and VANGUARD GROUP INC.
This page lists
169
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.